These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 17171847

  • 1. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice.
    Fed Regist; 2006 Dec 01; 71(231):69478-80. PubMed ID: 17171847
    [Abstract] [Full Text] [Related]

  • 2. Changes to patient limitation for dispensing or prescribing approved narcotic controlled substances for maintenance or detoxification treatment by qualified individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2008 May 22; 73(100):29685-8. PubMed ID: 18605404
    [Abstract] [Full Text] [Related]

  • 3. DEA issues proposed rule on e-prescribing.
    Ball FR.
    J Med Pract Manage; 2009 May 22; 24(4):243. PubMed ID: 19288650
    [Abstract] [Full Text] [Related]

  • 4. Exemption from import/export requirements for personal medical use. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice.
    Fed Regist; 2004 Sep 14; 69(177):55343-7. PubMed ID: 15366181
    [Abstract] [Full Text] [Related]

  • 5. Placement of gamma-butyrolactone in List I of the Controlled Substances Act (21 U.S.C. 802(34)). Drug Enforcement Administration, Justice. Final rule.
    Fed Regist; 2000 Apr 24; 65(79):21645-7. PubMed ID: 11010670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice.
    Fed Regist; 2005 Jun 23; 70(120):36338-44. PubMed ID: 15973789
    [Abstract] [Full Text] [Related]

  • 9. Amendment of the fee exemption for federal, state and local government employees--DEA, Justice. Final rule.
    Fed Regist; 1994 Feb 24; 59(37):8859. PubMed ID: 10133414
    [Abstract] [Full Text] [Related]

  • 10. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice.
    Fed Regist; 2007 Nov 19; 72(222):64921-30. PubMed ID: 18038486
    [Abstract] [Full Text] [Related]

  • 11. Drug enforcement administration liability for false arrest of physician.
    Brushwood DB.
    J Pain Palliat Care Pharmacother; 2009 Nov 19; 23(2):156-62. PubMed ID: 19492217
    [Abstract] [Full Text] [Related]

  • 12. The regulatory process: impacting the NP's role.
    Wysocki S.
    Nurse Pract Forum; 1992 Jun 19; 3(2):56-7. PubMed ID: 1392671
    [Abstract] [Full Text] [Related]

  • 13. Who defines "legitimate medical practice?" Lessons learned from the Controlled Substances Act, physician-assisted suicide, and Oregon v. Ashcroft.
    Gast S.
    Va J Soc Policy Law; 2002 Jun 19; 10(2):261-91. PubMed ID: 16493846
    [No Abstract] [Full Text] [Related]

  • 14. Dispensing of controlled substances to assist suicide. Interpretive rule.
    Department of Justice.
    Fed Regist; 2001 Nov 09; 66(218):56607-8. PubMed ID: 11760766
    [Abstract] [Full Text] [Related]

  • 15. Authorized sources of narcotic raw materials. Final rule.
    Fed Regist; 2008 Feb 06; 73(25):6843-51. PubMed ID: 18389916
    [Abstract] [Full Text] [Related]

  • 16. Exemption from registration for persons authorized under U.S. Nuclear Regulatory Commission or agreement state medical use licenses or permits and administering the drug product DaTscan(TM). Interim final rule with request for comment.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2014 Nov 25; 79(227):70085-90. PubMed ID: 25423689
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
    Fed Regist; 1983 Jun 28; 48(125):29713-4. PubMed ID: 10261481
    [Abstract] [Full Text] [Related]

  • 20. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice.
    Fed Regist; 2004 Sep 29; 69(188):58950-3. PubMed ID: 15455477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.